Fengna Chu
Changchun, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Differences in clinical phenotype, laboratory, and imaging manifestations between AQP4 IgG positive and AQP4 MOG IgG double negative NMOSD: How to correctly diagnose the two.
Journal: Autoimmunity reviews
Published: May 21, 2024
Peripheral blood amyloid-β involved in the pathogenesis of Alzheimer's disease via impacting on peripheral innate immune cells.
Journal: Journal of neuroinflammation
Published: October 24, 2023
Alleviation of experimental autoimmune encephalomyelitis by transferring low RelB expression tolerogenic dendritic cells.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: June 22, 2023
Low dose of levetiracetam counteracts amyloid β-induced alterations of hippocampal gamma oscillations by restoring fast-spiking interneuron activity.
Journal: Experimental neurology
Published: March 30, 2023
Discrepancy in clinical and laboratory profiles of NMOSD patients between AQP4 antibody positive and negative: can NMOSD be diagnosed without AQP4 antibody?
Journal: Clinical and experimental immunology
Published: December 04, 2022
Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer's Disease: A Focus on Aducanumab and Lecanemab.
Journal: Frontiers in aging neuroscience
Published: February 06, 2022
Progress in treatment of neuromyelitis optica spectrum disorders (NMOSD): Novel insights into therapeutic possibilities in NMOSD.
Journal: CNS neuroscience & therapeutics
Published: October 20, 2021
Potential role of BAY11-7082, a NF-κB blocker inhibiting experimental autoimmune encephalomyelitis in C57BL/6J mice via declining NLRP3 inflammasomes.
Journal: Clinical and experimental immunology
Published: September 04, 2021
Comparisons of clinical phenotype, radiological and laboratory features, and therapy of neuromyelitis optica spectrum disorder by regions: update and challenges.
Journal: Autoimmunity reviews
Published: July 28, 2021
Nuclear factor kappa B inhibitor suppresses experimental autoimmune neuritis in mice via declining macrophages polarization to M1 type.
Journal: Clinical and experimental immunology
Published: April 27, 2021
Can Control Infections Slow Down the Progression of Alzheimer's Disease? Talking About the Role of Infections in Alzheimer's Disease.
Journal: Frontiers in aging neuroscience
Published: March 25, 2021
Last Updated: 09/26/2026